{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T04:44:00Z","timestamp":1741668240567,"version":"3.38.0"},"reference-count":31,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Womens Health (Lond Engl)"],"published-print":{"date-parts":[[2012,5]]},"abstract":"<jats:p> Evaluation of: Gemzell-Danielsson K, Schellschmidt I, Apter D. A randomized, Phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena. Fertil. Steril. 97(3), 616\u2013622.e3 (2012). A randomized, open-label, Phase II study was conducted in 37 centers in five European countries to assess the optimal dose for a new contraceptive levonorgestrel intrauterine system (LNG-IUS). Overall, 742 parous or nulliparous women aged 21\u201340 years were allocated to receive a LNG-IUS that initially releases 12 \u00b5g\/day (LNG-IUS<jats:sub>12<\/jats:sub>) or 16 \u00b5g\/day (LNG-IUS<jats:sub>16<\/jats:sub>) in vitro or the currently available device that releases 20 \u00b5g\/day (LNG-IUS<jats:sub>20<\/jats:sub>). The two new devices are shorter than the current one. Pearl Indices of 0.17, 0.82 and 0.00 for the LNG-IUS<jats:sub>12<\/jats:sub>, LNG-IUS<jats:sub>16<\/jats:sub> and LNG-IUS<jats:sub>20<\/jats:sub>, respectively, reflect the contraceptive efficacy of these devices. The mean number of bleeding and spotting days decreased in all three groups; however, this decrease was more significant in LNG-IUS<jats:sub>20<\/jats:sub> users. Placement of the new shorter devices was considered simple by providers, while patients reported significantly less pain with the two new devices compared with the current one. This study provided further insight into the development of two new LNG-IUS devices as contraceptives, with the additional possibility of using them to treat heavy menstrual bleeding or as endometrial protection during estrogen therapy. <\/jats:p>","DOI":"10.2217\/whe.12.12","type":"journal-article","created":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T13:57:05Z","timestamp":1336053425000},"page":"235-238","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of the Use of Two New Low-Dose Levonorgestrel-Releasing Intrauterine Systems as Contraceptives"],"prefix":"10.1177","volume":"8","author":[{"given":"Luis","family":"Bahamondes","sequence":"first","affiliation":[{"name":"Human Reproduction Unit, Department of Obstetrics & Gynecology, School of Medical Sciences, University of Campinas (UNICAMP), Caixa Postal 6181, 13084-971 Campinas, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M Valeria","family":"Bahamondes","sequence":"additional","affiliation":[{"name":"Human Reproduction Unit, Department of Obstetrics & Gynecology, School of Medical Sciences, University of Campinas (UNICAMP), Caixa Postal 6181, 13084-971 Campinas, SP, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2012,5,1]]},"reference":[{"key":"bibr1a-WHE.12.12","unstructured":"Papers of special note have been highlighted as:"},{"key":"bibr1b-WHE.12.12","unstructured":"of interest"},{"key":"bibr1c-WHE.12.12","unstructured":"of considerable interest."},{"key":"bibr1-WHE.12.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2006.12.024"},{"key":"bibr2-WHE.12.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2009.06.005"},{"key":"bibr2a-WHE.12.12","unstructured":"Provides a review on long-acting reversible contraceptives."},{"key":"bibr3-WHE.12.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2004.12.026"},{"key":"bibr4-WHE.12.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2007.01.016"},{"key":"bibr5-WHE.12.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2006.12.005"},{"key":"bibr3a-WHE.12.12","unstructured":"Provides a review on the use of intrauterine devices (IUDs) in nulliparous women and the need for new short IUDs."},{"key":"bibr6-WHE.12.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2007.05.085"},{"key":"bibr4a-WHE.12.12","unstructured":"Provides data on the attitudes of UK doctors regarding long-acting reversible contraceptive methods."},{"key":"bibr7-WHE.12.12","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-200202000-00019"},{"key":"bibr5a-WHE.12.12","unstructured":"Provides data on the attitudes of US doctors regarding intrauterine contraceptives."},{"key":"bibr8-WHE.12.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.2010.01136.x"},{"key":"bibr9-WHE.12.12","first-page":"CD007373","volume":"3","author":"Allen RH","year":"2009","journal-title":"Cochrane Database Syst. Rev"},{"key":"bibr6a-WHE.12.12","unstructured":"Provides data on the usefulness of different treatments during intrauterine contraceptive placement."},{"key":"bibr10-WHE.12.12","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(95)00210-2"},{"key":"bibr7a-WHE.12.12","unstructured":"Provides a review on the levonorgestrel-releasing intrauterine system."},{"key":"bibr11-WHE.12.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2010.01.006"},{"key":"bibr12-WHE.12.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2010.01.010"},{"key":"bibr8a-WHE.12.12","unstructured":"Extensive review on the use of intrauterine contraception in nulligravida and nulliparous women."},{"key":"bibr13-WHE.12.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2011.05.012"},{"key":"bibr14-WHE.12.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.12.003"},{"key":"bibr15-WHE.12.12","doi-asserted-by":"publisher","DOI":"10.1016\/0010-7824(86)90006-5"},{"key":"bibr16-WHE.12.12","doi-asserted-by":"publisher","DOI":"10.1097\/00004347-198609000-00005"},{"key":"bibr17-WHE.12.12","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/del029"},{"key":"bibr9a-WHE.12.12","unstructured":"Provides data on treatment for pain control during IUD placement."},{"key":"bibr18-WHE.12.12","doi-asserted-by":"publisher","DOI":"10.1080\/j.1600-0412.1999.780810.x"},{"key":"bibr19-WHE.12.12","doi-asserted-by":"publisher","DOI":"10.1080\/02699200802253706"},{"key":"bibr20-WHE.12.12","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181ec622b"}],"container-title":["Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.2217\/WHE.12.12","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.2217\/WHE.12.12","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.2217\/WHE.12.12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T01:54:25Z","timestamp":1741658065000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.2217\/WHE.12.12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["10.2217\/WHE.12.12"],"URL":"https:\/\/doi.org\/10.2217\/whe.12.12","relation":{},"ISSN":["1745-5057","1745-5065"],"issn-type":[{"type":"print","value":"1745-5057"},{"type":"electronic","value":"1745-5065"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}